Clinical Trial

Liver Transplant Clinical Trial 20193078

[LCID Study Number: 20193078]

Incidence and Effect of HLA Antibodies in Liver Transplant Recipients

The purpose of this study is to determine how often liver transplant patients have HLA antibodies, when they develop, and whether or not they are associated with poor graft function or loss.

Disease/Condition: Liver Transplant

Department: Transplantation & Hepatobiliary Diseases

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Clinical Trial Details

Protocol #: 20193078

Principal Investigator(s): Mary Ann Simpson

Study Coordinator(s): Ali Jaber

Trial Phase: Investigator Initiated Study Observational